Work

Cepharanthine Reverses Gefitinib Resistance in NSCLC by Concurrently Inhibiting AKT / P70S6K Survival Signaling and Activating STING ‐Mediated Immune Response

Year: 2026

Type: article

Source: Chemical Biology & Drug Design

DOI: 10.1111/cbdd.70298

Authors: Li‐Ping Kang, Hui‐Hui Chen, Tong‐Tong Lv, Hua‐Jing Huang, Dong‐Hui Huang, Ying‐Qing Chen, Ze‐Bo Jiang

Institutions: Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Northeastern University, Dalian University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: China Postdoctoral Science Foundation, Basic and Applied Basic Research Foundation of Guangdong Province

Awards: G2089982207, G4750969998, G8207265954

OpenAlex ID: W7158805507

FWCI: 4.379

Cites:

Cited by: 1

Related to: